Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$147M |
| 2 |
Broadcom
AVGO
|
+$140M |
| 3 |
Builders FirstSource
BLDR
|
+$117M |
| 4 |
Equinix
EQIX
|
+$99.7M |
| 5 |
ConocoPhillips
COP
|
+$82.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GameStop
GME
|
+$464M |
| 2 |
Chevron
CVX
|
+$257M |
| 3 |
Apple
AAPL
|
+$250M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.62% |
| 3 | Industrials | 13.76% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Friedman Industries
FRD
$240M
| $4.4M | ﹤0.01% |
543,513
-9,419
| -2% | -$72.9K |
|
2627
Trupanion
TRUP
$1.07B
| $4.35M | ﹤0.01% |
57,048
+19,669
| +53% | +$2.02M |
|
|
HALL
2628
DELISTED
Hallmark Financial Services, Inc.
HALL
| $4.34M | ﹤0.01% |
111,808
-8,943
| -7% | -$342K |
|
|
DOYU
2629
DouYu International Holdings
DOYU
$139M
| $4.32M | ﹤0.01% |
41,557
+18,600
| +81% | +$2.52M |
|
|
HIL
2630
DELISTED
Hill International, Inc. Common Stock
HIL
| $4.32M | ﹤0.01% |
1,350,794
+84,453
| +7% | +$218K |
|
|
SFE
2631
DELISTED
Safeguard Scientifics, Inc.
SFE
| $4.3M | ﹤0.01% |
630,535
-80,326
| -11% | -$583K |
|
|
BMTX
2632
DELISTED
BM Technologies, Inc.
BMTX
| $4.28M | ﹤0.01% |
366,722
+103,352
| +39% | +$1.4M |
|
2633
Stoke Therapeutics
STOK
$1.8B
| $4.22M | ﹤0.01% |
108,823
+69,010
| +173% | +$3.93M |
|
|
NGM
2634
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.21M | ﹤0.01% |
145,264
+74,332
| +105% | +$2.08M |
|
2635
Value Line
VALU
$321M
| $4.18M | ﹤0.01% |
148,366
-4,463
| -3% | -$134K |
|
2636
Liberty Global Class A
LBTYA
$3.62B
| $4.18M | ﹤0.01% |
162,770
-897
| -0.5% | -$22.7K |
|
|
CRON
2637
Cronos Group
CRON
$1.06B
| $4.15M | ﹤0.01% |
438,302
+112,298
| +34% | +$1.19M |
|
2638
Mastech Digital
MHH
$93.1M
| $4.13M | ﹤0.01% |
234,729
-2,274
| -1% | -$38.8K |
|
2639
Pacific Biosciences
PACB
$435M
| $4.12M | ﹤0.01% |
+123,172
| New | +$4.31M |
|
2640
TG Therapeutics
TGTX
$7.96B
| $4.11M | ﹤0.01% |
85,253
+79,765
| +1,453% | +$3.83M |
|
2641
Magnolia Oil & Gas
MGY
$6.09B
| $4.1M | ﹤0.01% |
+357,246
| New | +$3.72M |
|
2642
Dawson Geophysical
DWSN
$145M
| $4.07M | ﹤0.01% |
1,662,739
+5,025
| +0.3% | +$14K |
|
|
FCCY
2643
DELISTED
1st Constitution Bancorp
FCCY
| $4.06M | ﹤0.01% |
230,538
+10,083
| +5% | +$176K |
|
|
DZSI
2644
DELISTED
DZS Inc. Common Stock
DZSI
| $4.04M | ﹤0.01% |
260,101
+35,546
| +16% | +$592K |
|
2645
BayCom
BCML
$329M
| $4.03M | ﹤0.01% |
223,645
+14,184
| +7% | +$232K |
|
2646
Landmark Bancorp
LARK
$191M
| $4.03M | ﹤0.01% |
195,570
+9,692
| +5% | +$195K |
|
|
FLNT
2647
Fluent
FLNT
$102M
| $4.02M | ﹤0.01% |
162,844
+55,856
| +52% | +$1.94M |
|
2648
Westwood Holdings Group
WHG
$182M
| $3.99M | ﹤0.01% |
276,236
-22,495
| -8% | -$344K |
|
2649
CytomX Therapeutics
CTMX
$675M
| $3.98M | ﹤0.01% |
515,051
-38,853
| -7% | -$308K |
|
2650
Apyx Medical
APYX
$173M
| $3.98M | ﹤0.01% |
411,950
+33,391
| +9% | +$334K |
|
Similar funds
Dimensional Fund Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Dimensional Fund Advisors held 3,466 positions worth $302B, up 9.2% from $277B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Dimensional Fund Advisors's Q1 2021 filing shows 123 new, 1,208 increased, 1,942 reduced and 57 closed positions. Its largest new stake was Cognyte Software: 1,291,244 shares worth $35.9M. The largest sale was GameStop, an estimated $464M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2021 buy was Cognyte Software: 1,291,244 shares worth $35.9M.
- Dimensional Fund Advisors added most to International Flavors & Fragrances in Q1 2021, an estimated $147M increase.
- Dimensional Fund Advisors's biggest Q1 2021 reduction was GameStop, cutting an estimated $464M.
- Dimensional Fund Advisors fully exited BMC Stock Holdings, Inc in Q1 2021, selling an estimated $197M.
- Dimensional Fund Advisors's ten largest holdings make up 9.8% of its $302B portfolio in Q1 2021.
- Dimensional Fund Advisors opened 123 new positions and closed 57 in Q1 2021.
- Dimensional Fund Advisors's portfolio value rose 9.2% quarter-over-quarter to $302B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.